Vaccine News and Research

Latest Vaccine News and Research

New scientific statement outlines recommendations for diagnosing, managing cerebral venous thrombosis

A new scientific statement from the American Heart Association emphasizes the need to increase patients' and physicians' awareness of cerebral venous thrombosis (CVT) to improve the recognition of this condition and initiate prompt medical treatment.

29 Jan 2024

How fringe anti-science views infiltrated mainstream politics — and what it means in 2024

Rates of routine childhood vaccination hit a 10-year low in 2023. That, according to the Centers for Disease Control and Prevention, puts about 250,000 kindergartners at risk for measles, which often leads to hospitalization and can cause death.

29 Jan 2024

Prior exposure to common cold coronaviruses can train T cells to fight SARS-CoV-2

Scientists at La Jolla Institute for Immunology (LJI) have found direct evidence that exposure to common cold coronaviruses can train T cells to fight SARS-CoV-2. In fact, prior exposure to a common cold coronavirus appears to partially protect mice from lung damage during a subsequent SARS-CoV-2 infection.

27 Jan 2024

New study opens unprecedented opportunities for bioengineering vaccine adjuvants

A valuable molecule sourced from the soapbark tree and used as a key ingredient in vaccines, has been replicated in an alternative plant host for the first time, opening unprecedented opportunities for the vaccine industry.

26 Jan 2024

Clinical study supports the long-lasting impacts of typhoid conjugate vaccine

A single dose of the typhoid conjugate vaccine, Typbar TCV, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study conducted by researchers at University of Maryland School of Medicine's (UMSOM) Center for Vaccine Development and Global Health (CVD) and led by in-country partners at the Malawi-Liverpool Wellcome Trust (MLW) Clinical Research Programme.

25 Jan 2024

Do yellow fever vaccines truly provide effective lifelong protection against the disease after a single dose?

The long-term protection offered by one dose of vaccine against yellow fever.

25 Jan 2024

Study confirms safety of COVID-19 vaccination during pregnancy for infant neurodevelopment

A large cohort study in "JAMA Pediatrics" found no significant differences in neurodevelopmental rates between infants exposed to COVID-19 vaccines in-utero and those who were not, affirming the safety of maternal COVID-19 vaccination.

24 Jan 2024

Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine

Researchers analyzed the toxicity concerns and advancements in mRNA therapeutics, focusing on their cellular toxicity, reactogenicity, and distribution, and discussed the challenges and benefits of mRNA research.

24 Jan 2024

Maternal COVID-19 vaccination equally benefits preterm and full-term babies

A study in JAMA Network Open reveals that maternal COVID-19 vaccination provides similar antibody levels in preterm and full-term infants' cord blood, with higher doses leading to increased antibodies.

24 Jan 2024

Researchers secure $1.5 million grant to eliminate barriers from cervical cancer prevention

A research team from LSU LCMC Health Cancer Center has been awarded a $1.5 million grant to eliminate barriers from cervical cancer prevention. The five-year program combines a $1.2 million award from the American Cancer Society and $75,000 a year for five years investment from LSU Health New Orleans.

24 Jan 2024

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

The UK Health Security Agency (UKHSA) has today published its Pathogen Genomics Strategy, laying out a 5 year plan for the organization's role in the wider delivery of pathogen genomics to prepare for and respond to infectious disease threats to public health.

24 Jan 2024

Study finds three times the risk of respiratory distress in infants born to COVID-infected mothers

New UCLA-led research finds that infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed infants, even though they themselves were not infected with the virus.

24 Jan 2024

Persistent presence of SARS-CoV-2 RNA found in long COVID patients

Previous
1
...
39
40
41
42
43
44
45
...
1122
Next

Vaccine News and Research

Latest Vaccine News and Research

New scientific statement outlines recommendations for diagnosing, managing cerebral venous thrombosis

How fringe anti-science views infiltrated mainstream politics — and what it means in 2024

Prior exposure to common cold coronaviruses can train T cells to fight SARS-CoV-2

New study opens unprecedented opportunities for bioengineering vaccine adjuvants

Clinical study supports the long-lasting impacts of typhoid conjugate vaccine

Do yellow fever vaccines truly provide effective lifelong protection against the disease after a single dose?

Study confirms safety of COVID-19 vaccination during pregnancy for infant neurodevelopment

Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine

Maternal COVID-19 vaccination equally benefits preterm and full-term babies

Researchers secure $1.5 million grant to eliminate barriers from cervical cancer prevention

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

Study finds three times the risk of respiratory distress in infants born to COVID-infected mothers

Persistent presence of SARS-CoV-2 RNA found in long COVID patients

Effects of varying COVID-19 vaccination rates on population-level health outcomes across variant waves in the U.S.

Montana’s effort to expand religious exemptions to vaccines prompts political standoff

Memory T cells learn and adapt: Post-Omicron immunity offers wider protection

New instruction manual could help scientists find hard-to-detect B cells

Study shows Omicron variants evade immune system like predecessors, suggesting key evolutionary trait in SARS-CoV-2

The crucial need for ongoing COVID-19 booster vaccination in vulnerable populations

Researchers develop a potential one-minute COVID-19 test inspired by bioluminescence

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Vaccine News and Research

Latest Vaccine News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in